title: Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.
abstract: Management of Venous thromboembolism (VTE) in cancer patients is difficult when guidelines are inconclusive. To share a reasonable and homogeneous behavior in such circumstances, four issues, which are felt as problematic by oncologists and surgeons, have been selected; all were uncovered or only partially covered by current guidelines. Results from the literature and author's specific experience in the field were utilized to suggest reasonable solutions to the raised questions. The reported experience is the first to provide real-world management guidance for VTE in cancer patients. The effort of putting together literature review and author's experience brought to the adoption of a common behavior.
authors.affiliation: Respiratory Unit, Cardiothoracic and Vascular Department, University of Pisa , Pisa Italy.
authors.forename: A
authors.initials: A
authors.lastname: Palla
authors.forename: A
authors.initials: A
authors.lastname: Celi
authors.forename: L
authors.initials: L
authors.lastname: Marconi
authors.forename: F
authors.initials: F
authors.lastname: Pistelli
authors.forename: L
authors.initials: L
authors.lastname: Tavanti
authors.forename: M
authors.initials: M
authors.lastname: Desideri
authors.forename: L
authors.initials: L
authors.lastname: Carrozzi
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D011655:Pulmonary Embolism / Q000188:drug therapy; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight
keywords: Cancer; Decision-making; Venous thromboembolism